Explore / Peer-reviewed article
Peer-reviewed articleOpen access

Distinctive patterns of G protein coupling induced by the structurally similar 5-HT<sub>2A</sub> receptor ligands ketanserin and altanserin in human prefrontal cortex.

Miranda-Azpiazu PiD, Muguruza CiD, Stepniewski TMiD, Muneta-Arrate I, Moreira D, Brea JiD, Callado LFiD, Loza MI, González-Maeso JiD, Selent JiD, Diez-Alarcia R, Meana JJ

Molecular pharmacologySep 24, 2025License: open accessSpain, Poland2 citationsDOI: 10.1016/j.molpha.2025.100075

Abstract

Antipsychotic activity of certain 5-HT<sub>2A</sub> receptor (5-HT<sub>2A</sub>R) antagonists has been attributed to inverse agonism. 5-HT<sub>2A</sub>R hallucinogenic agonists exhibit biased agonism toward G<sub>i/o</sub> proteins. Ketanserin and altanserin are 2 structurally similar orthosteric drugs used as 5-HT<sub>2A</sub>R therapeutic and radiotracers tools. This study assessed the pharmacological properties of ketanserin and altanserin, previously described as neutral 5-HT<sub>2A</sub>R antagonists, using postmortem human prefrontal cortex. Receptor radioligand binding experiments and functional [<sup>35</sup>S]GTPγS (sulfur 35 labeled guanosine-5'-O-[gamma-thio]-triphosphate) binding assays followed by immunocapture with anti-Gα<sub>q/11</sub> and anti-Gα<sub>i1</sub> protein antibodies were performed. Molecular dynamics simulations were used to ascertain binding modes to the 5-HT<sub>2A</sub>R. [<sup>3</sup>H]Ketanserin binding to 5-HT<sub>2A</sub>Rs was decreased by guanylyl-5'-imido-diphosphate, a GTP analog. Guanylyl-5'-imido-diphosphate transformed the biphasic inhibition of [<sup>3</sup>H]ketanserin binding by the agonist (±)DOI into a monophasic low-affinity curve. Ketanserin stimulated [<sup>35</sup>S]GTPγS binding to Gα<sub>q/11</sub> but not Gα<sub>i1</sub> proteins. Conversely, altanserin inhibited [<sup>35</sup>S]GTPγS binding to Gα<sub>i1</sub> but not Gα<sub>q/11</sub> proteins. These effects were blocked by the neutral antagonist MDL-11,939. Altanserin-induced inhibition was abolished by the Gα<sub>i/o</sub> alkylating agent N-ethylmaleimide. Similar findings were observed in wild type but disappeared in 5-HT<sub>2A</sub>R knockout mice. Ketanserin and altanserin showed distinct interactions within residues S2.61, S5.46, and N6.55 in the 5-HT<sub>2A</sub>R binding pocket. Therefore, ketanserin and altanserin elicit biased signaling with different patterns of G protein modulation upon interacting with 5-HT<sub>2A</sub>Rs in brain. Ketanserin behaves as partial agonist on G<sub>q/11</sub>, whereas altanserin acts as inverse agonist on G<sub>i1</sub> proteins. These findings should influence the design of antipsychotic drugs targeting this receptor and when used as antagonists and radiotracers for the 5-HT<sub>2A</sub>R assessment. SIGNIFICANCE STATEMENT: Ketanserin and altanserin are categorized as neutral 5-HT<sub>2A</sub> receptor antagonists. This study shows differential patterns of 5-HT<sub>2A</sub> receptor coupling to Gα<sub>q/11</sub> and Gα<sub>i1</sub> proteins between ketanserin and altanserin and demonstrates biased signaling and inverse agonism in human brain.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Psychedelics

Keywords

G proteinAntipsychoticInverse AgonismBiased AgonismFunctional Selectivity5-Ht(2a) Receptor

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.